UBS, Lawmakers

UBS Lawmakers Hit Pause on Capital Rules as Bank Prunes Overseas Operations

Published on 09/20/2026 at 11:20 | Editorial boerse-global.de

Swiss lawmakers adjourned debate on UBS's capital framework, leaving a 50% AT1 compromise and roughly USD 13 billion in fresh capital unresolved.

Moderner Bankschalter mit Glaspartitionen und Stahltresor im Hintergrund
UBS Group AG CH0244767585 zeigt einen modernen Bankschalterbereich mit eleganten Glaspartitionen und massiver Stahl-TresortĂĽr Illustration mit AI erstellt.

Switzerland's parliament has kicked the can down the road on the country's most consequential banking regulation in years, leaving UBS Group's capital burden — and its long-term commitment to its home market — hanging in the balance.

Lawmakers in the Council of States adjourned debate on the government's capital framework after Andrea Caroni withdrew his motion to send the draft back to the Federal Council. The move, made on Thursday, preserves the legislation but delays any resolution, keeping the bank and its investors in a holding pattern over how much extra equity it will ultimately be forced to hold following its absorption of Credit Suisse.

The AT1 Compromise on the Table

At the heart of the wrangling is how strictly foreign subsidiaries must be capitalized. A compromise circulating in Bern would permit those units to be backed 50% with additional tier 1 (AT1) capital — a far lighter touch than the Federal Council's original proposal. Reuters, citing investors on Tuesday, reported the arrangement could save the lender several hundred million dollars annually.

Finance Minister Karin Keller-Sutter has pushed back on that softening, arguing against diluting the original blueprint. UBS, for its part, has welcomed the search for alternatives while cautioning that even the watered-down version would still demand roughly USD 13 billion in fresh capital.

Should investors sell immediately? Or is it worth buying UBS?

Kelleher's Warning Shot

The stakes were laid bare by Chairman Colm Kelleher, who said on Thursday that the bank would have to scrutinize its future in Switzerland should the new rules prove so onerous that it can no longer compete internationally. His comments — reported by Reuters — came after a committee reviewed UBS's capital buffers last Friday without resolving management's concerns.

The tension is not merely philosophical. A sharp tightening of requirements would weigh on return on equity and crimp the bank's capacity for future payouts, giving management every incentive to press for rules that stay proportionate by global standards.

JPMorgan Lifts Its Target

Analysts are not waiting for Bern to make up its mind. On 8 September, JPMorgan raised its price target on the stock from CHF 46 to CHF 50 while reaffirming an "Overweight" rating.

The shares closed Friday at EUR 43.71, down 0.9% on the session, though they remain up 9.9% year to date.

Balance Sheet Housekeeping Continues

While politicians deliberate, UBS is steadily reshaping its liabilities and trimming peripheral businesses. The bank extended its bond buyback program about two weeks ago, further altering its capital structure, and has slated the full repayment of GBP 750,000,000 in outstanding senior callable notes for 30 September 2026. The fixed-rate issue carries a 7.000% coupon.

UBS at a turning point? This analysis reveals what investors need to know now.

On the distribution side, UBS will shut its Shenzhen fund sales unit — launched in late 2022 — by the end of September, winding down the WE.UBS digital platform in China. Other wealth management channels in the country are unaffected and will continue as planned, as the group refocuses on its established asset-gathering markets.

Until the Swiss parliament settles the capital question, the debate over where UBS books its business and how much cushion it must hold will keep shaping the stock's trajectory.

Ad

UBS Stock: New Analysis - 20 September

Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated UBS analysis...

Disclaimer...

en | CH0244767585 | UBS | boerse | 70136101 |